Biovica International AB (publ) (BIOVIC-B) - Total Liabilities

Latest as of July 2025: Skr31.14 Million SEK ≈ $3.35 Million USD

Based on the latest financial reports, Biovica International AB (publ) (BIOVIC-B) has total liabilities worth Skr31.14 Million SEK (≈ $3.35 Million USD) as of July 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Biovica International AB (publ) - Total Liabilities Trend (2014–2025)

This chart illustrates how Biovica International AB (publ)'s total liabilities have evolved over time, based on quarterly financial data. See working capital to net assets of Biovica International AB (publ) to evaluate short-term liquidity relative to the company's equity base.

Biovica International AB (publ) Competitors by Total Liabilities

The table below lists competitors of Biovica International AB (publ) ranked by their total liabilities.

Company	Country	Total Liabilities
Buxton Resources Ltd AU:BUX	Australia	AU$300.90K
NFL Biosciences SAS PA:ALNFL	France	€2.60 Million
Co-Diagnostics, Inc. Common Stock NASDAQ:CODX	USA	$5.46 Million
Medicon Hellas S.A. AT:MEDIC	Greece	€14.85 Million
Edinburgh Investment Trust LSE:EDIN	UK	GBX121.94 Million
Cannabist Company Holdings Inc NEO:CBST	Canada	CA$689.46 Million
HEBEI CONSTR.GRP CORP YC1 F:H9D	Germany	€42.04 Billion
Sri Adhikari Brothers Television Network Limited NSE:SABTNL	India	Rs171.45 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Biovica International AB (publ)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see BIOVIC-B market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.86	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	0.56	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.21	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.55	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Biovica International AB (publ)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Biovica International AB (publ) (2014–2025)

The table below shows the annual total liabilities of Biovica International AB (publ) from 2014 to 2025.

Year	Total Liabilities	Change
2025-04-30	Skr21.74 Million ≈ $2.34 Million	-37.46%
2024-04-30	Skr34.77 Million ≈ $3.74 Million	+3.32%
2023-04-30	Skr33.65 Million ≈ $3.62 Million	+22.18%
2022-04-30	Skr27.54 Million ≈ $2.96 Million	+175.73%
2021-04-30	Skr9.99 Million ≈ $1.07 Million	-17.05%
2020-04-30	Skr12.04 Million ≈ $1.30 Million	+37.43%
2019-04-30	Skr8.76 Million ≈ $942.93K	+24.14%
2018-04-30	Skr7.06 Million ≈ $759.55K	+25.19%
2017-04-30	Skr5.64 Million ≈ $606.74K	+73.26%
2016-04-30	Skr3.25 Million ≈ $350.18K	-65.54%
2015-04-30	Skr9.44 Million ≈ $1.02 Million	+134.67%
2014-04-30	Skr4.02 Million ≈ $433.09K	--

About Biovica International AB (publ)

ST:BIOVIC-B Sweden Biotechnology

Market Cap

$12.41 Million

Skr115.35 Million SEK

Market Cap Rank

#26502 Global

#572 in Sweden

Share Price

Skr0.42

Change (1 day)

+14.79%

52-Week Range

Skr0.28 - Skr0.84

All Time High

Skr66.10